cyclosporine and Uveitis

cyclosporine has been researched along with Uveitis in 120 studies

Research

Studies (120)

TimeframeStudies, this research(%)All Research%
pre-19904 (3.33)18.7374
1990's47 (39.17)18.2507
2000's26 (21.67)29.6817
2010's36 (30.00)24.3611
2020's7 (5.83)2.80

Authors

AuthorsStudies
Hasumi, Y; Ida, Y; Ishihara, M; Kawano, S; Kimura, I; Mizuki, N; Shibuya, E; Takeuchi, M; Yamane, T1
Alafaleq, M; Bodaghi, B; Deray, G; Fardeau, C; Freund, R; Isnard-Bagnis, C; LE Hoang, P; Penet, MA; Tezenas du Montcel, S; Tostivint, I1
Duan, R; Gao, Y; Li, H; Lin, X; Liu, X; Su, W; Tao, T; Wang, R; Xie, L; Yang, S1
Abu El-Asrar, AM; Albloushi, AF; Alkheraiji, NF; Almater, AI; Alromaih, AZ1
Cisło-Pakuluk, A; Marycz, K; Padjasek, M; Qasem, B1
Chen, Y; Xu, H1
Maruyama, K1
Basu, S; Damera, S; Kaza, H; Parai, D; Rana, K; Tagirasa, R1
Bähler, H; Bauer, D; Busch, M; Heiligenhaus, A; Kasper, M; Pacheco-López, G; Schedlowski, M; Schröder, M; Thanos, S; Walscheid, K; Wildschütz, L1
Bauer, D; Böhm, MRR; Busch, M; Courthion, H; Gabriel, D; Gurny, R; Heiligenhaus, A; Kasper, M; Loser, K; Möller, M; Rodriguez-Aller, M; Thanos, S; Wildschütz, L1
Guex-Crosier, Y; Ribi, C; Rossi, DC1
Abul Kalam, M; Ali, R; Alshamsan, A; Alturki, TA; Binkhathlan, Z; Lavasanifar, A; Raish, M; Safaei Nikouei, N; Vakili, MR1
Joshi, L; Lightman, S; McCluskey, P; Sandhu, S; Talat, L; Taylor, SR; Wakefield, D; Yaganti, S1
Airò, P; Cavazzana, I; Franceschini, F; Fredi, M; Nascimbeni, G; Taraborelli, M; Tincani, A1
Bascherini, V; Cantarini, L; Caso, F; Costa, L; Franceschini, R; Latronico, E; Rigante, D; Vitale, A1
Basile, L; Calafiore, S; Ciarnella, A; Guglielmelli, F; Laganà, B; Mutolo, MG; Recupero, SM; Verrilli, S1
Adán, A; Lee, RW; Llorenç, V; Mesquida, M; Molins, B; Pelegrín, L1
Deuter, C; Doycheva, D; Zierhut, M1
López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L1
Liu, X; Zhang, M1
Chung, YR; Lee, ES; Lee, K; Park, JY; Song, JH1
Abe, S; Ebe, H; Hagiwara, S; Hoshi, S; Kondo, Y; Kurata, I; Matsumoto, I; Ogishima, H; Oshika, T; Sumida, T; Suzuki, T; Takahashi, H; Tsuboi, H; Umeda, N1
Adan, AM; Aparicio, Á; Blanco, A; Blanco, R; Calvo-Río, V; Cordero-Coma, M; Fonollosa, A; García Serrano, JL; González-Gay, MA; González-Suárez, S; González-Vela, C; Herreras, JM; Loricera, J; Maíz, O; Mesquida, M; Ortego-Centeno, N; Peiteado-Lopez, D; Pina, T; Riancho-Zarrabeitia, L; Sánchez-Bursón, J; Santos-Gómez, M1
Basiaga, ML; Behrens, EM; Weiss, PF1
Fang, C; He, Y; Huang, C; Li, J; Lin, Z; Zhan, S; Zhou, D1
Aktas, Z; Cubuk, MO; Gurelik, G; Hasanreisoglu, B; Hasanreisoglu, M; Ozdek, S1
Jones, N1
Shalaby, U1
Gery, I1
Chan, CC; Sen, HN; Tabbara, KF1
Smith, WM1
Ganser, G; Heiligenhaus, A; Heinz, C; Michels, H; Roesel, M; Tappeiner, C1
Anglade, E; Austin, BA; Chan, CC; Cunningham, MA; Li, Z; Liu, B; Nussenblatt, RB; Velagaleti, P; Yeh, S1
Angeles-Han, S; Flynn, T; Lehman, T1
Cağil, N; Erten, S; Midillioğlu, IK; Orhan, N; Simşek, S; Yülek, F1
Kamoi, K; Kawaguchi, T; Mochizuki, M; Sugita, S; Tanaka, H; Yamada, Y1
Daniel, E; Foster, CS; Gangaputra, S; Jabs, DA; Kaçmaz, RO; Kempen, JH; Levy-Clarke, GA; Newcomb, C; Nussenblatt, RB; Rosenbaum, JT; Suhler, EB; Thorne, JE1
Deuter, CM1
Brooks, DE; Clode, AB; Gilger, BC; Komaromy, AM; McMullen, RJ; Salmon, JH; Utter, ME; Wilkie, DA1
Horie, S; Kaneko, S; Mochizuki, M; Sugita, S; Yamada, Y1
Al-Obeidan, SS; El-Asrar, AM; Geboes, K; Kangave, D; Opdenakker, G; Struyf, S; Van Damme, J1
Denniston, AK; Murray, PI; Sreekantam, S1
Chung, H; Lee, SH; Yu, HG1
Arevalo, JF; Benitez-Del-Castillo, JM; Blanco, R; Cordero-Coma, M; Díaz-Llopis, M; Fernandez-Cid, C; Fonollosa, A; Garcia-Aparicio, AM; Garcia-de-Vicuña, C; Olea, JL; Ortega, G; Ortego, N; Rio-Pardo, MJ; Salom, D; Suarez-de-Figueroa, M1
Fujino, Y; Kaburaki, T; Kawashima, H; Okinaga, K; Takamoto, M; Yoshida, A1
Heiligenhaus, A; Heinz, C; Hennig, M; Rammrath, D; Roesel, M; Zurek-Imhoff, B1
Balaskas, K; Eperon, S; Guex-Crosier, Y; Gurny, R; Rodriguez-Aller, M1
Heiligenhaus, A; Heinz, C; Hoeft, S; Hudde, T; Neudorf, U; Steuhl, KP1
Beaufils, H; Deray, G; Isnard Bagnis, C; Jaudon, MC; Jouanneau, C; LeHoang, P; Maksud, P; Mallet, A; Tezenas du Montcel, S1
Cusmai, A; Dammacco, R; Frassanito, MA; Fusaro, T; Guerriero, S; Sborgia, C1
Androudi, S; Brazitikos, P; Christen, W; Fiore, T; Foster, CS; Iaccheri, B; Meniconi, M1
Büscher, R; Hoyer, PF; Hudde, T; Vester, U; Vij, O1
Pleyer, U; Schmidt, S1
Pleyer, U1
Gül, A; Inanc, M; Kamali, S; Kasapoglu, E; Mudun, A; Tugal-Tutkun, I; Urgancioglu, M1
Dong, XG; Shi, WY; Wang, SG; Xie, LX; Xu, YM; Yuan, GQ1
Dong, X; Lin, P; Shi, W; Wang, S; Xie, L; Yuan, G1
Barbera, L; Mora, P; Orsoni, JG; Toscani, M; Vecchi, M1
He, Y; Liu, YL; Ma, ZZ; Wang, JC; Zhang, Q; Zhu, XA1
He, Y; Liu, Y; Lu, W; Ma, Z; Wang, J; Zhang, Q; Zhang, X; Zhu, X1
Balbaba, M; Demir, N; Demir, T; Gödekmerdan, A; Ilhan, F; Türkçüoglu, P1
Bagnis, CI; Bodaghi, B; Deray, G; du Montcel, ST; Jaudon, MC; Le Hoang, P; Mallet, A; Tostivint, I1
Dick, AD; Hogan, AC; Lee, RW; McAvoy, CE1
Bang, D; Bodaghi, B; Chamberlain, AM; Gul, A; Hatemi, G; Houman, MH; Kötter, I; Olivieri, I; Salvarani, C; Sfikakis, PP; Silman, A; Siva, A; Stanford, MR; Stübiger, N; Yazici, H; Yurdakul, S1
Aldigeri, R; Carta, A; Ceglarek, U; Manzotti, F; Mora, P; Orsoni, JG; Zavota, L1
Benchekroun, N; Berraho-Hamani, A; Chaoui, Z; el Aouni, A; Hajji, Z; Ouazzani, B1
Ashton, P; Blandford, DL; Jaffe, GJ; Martin, DF; Nussenblatt, RB; Pearson, PA1
Boguszaková, J; Havlíková, M; Michalová, K; Poch, T; Ríhová, E1
Chan, CC; DeBarge, LR; Martin, DF; Nussenblatt, RB; Roberge, FG1
Lang, LS; Robertson, SM1
Bianchi, E; Carone, M; Castellino, P; d'Alessio, O; de Pascale, E; Giordano, M; Luzi, L; Pluvio, C; Vergani, S1
Fernandez Lucas, M; Gonzalo, A; Orte, L; Ortuño, J; Quereda, C; Sabater, J; Soria, C1
Nussenblatt, RB; Salvo, EC; Whitcup, SM1
Bambara, LM; Biasi, D; Botto, M; Caramaschi, P; Cortina, P; Girelli, D; Lombardo, G; Lunardi, C; Pacor, ML; Urbani, G1
Aresu, G; Barca, L; Frongia, T; Pascalis, L; Pia, G1
Lee, FD; Morris, AJ; Murphy, EA; Sturrock, RD; Walker, E1
de Smet, MD; Nussenblatt, RB1
Bechtel, U; Feucht, HE; Lund, OE; Thurau, SR1
Bloom, JN; Davis, J; de Smet, MD; Freidlin, V; Herman, D; Nussenblatt, RB; Rubin, B; Sran, PK; Whitcher, S; Whitcup, SM1
Foster, CS; Rodriguez, A; Vitale, AT1
Fukushima, A; Gery, I; Nussenblatt, RB; Whitcup, SM1
Matthews, AG1
Champagne, ES; Gratzek, AT; Kaswan, RL; Martin, CL; White, SL1
Ashton, P; Enyedi, LB; Jaffe, GJ; Pearson, PA1
Neidhart, M1
Cantarovich, M; Deschênes, J; Rocha, G1
Nussenblatt, RB; Whitcup, SM1
de Smet, MD; Nussenblatt, RB; Ramadan, AM1
Mochizuki, M1
Nussenblatt, RB1
Dick, AD; Forrester, JV; Kreutzer, B; Laliotou, B1
Akyol, N; Değer, O; Erdöl, H; Gedik, Y; Imamoglu, HI; Orem, A1
Epstein, RJ; Hendricks, RL; Lipman, RM1
Dick, AD; Forrester, JV; Kilmartin, DJ1
Goto, H; Kezuka, T; Matuura, G; Usui, M; Yamakawa, N1
ten Hoopen-Neumann, H; van der Meijden, WI; van Hagen, PM1
Fortin, E; Goldman, CK; Nussenblatt, RB; Rizzo, L; Schiffman, R; Smith, J; Sran, P; Van Veldhuisen, P; Waldmann, TA; Whitcup, SM; Yaffe, A1
Kaplan, HJ; Van Gelder, RN1
BenEzra, D; Cohen, E; Maftzir, G1
Allen, JB; Ashton, P; Gilger, BC; Horohov, D; Jaffe, GJ; Malok, E; Smith, T; Stewart, T1
Kulkarni, P1
Bimstein, E; Irshied, J1
Allen, JB; Davidson, MG; Gilger, BC; Wilkie, DA1
Bondartschuk, K; Fricke, B; Friedrich, R; Illéssy, A; Klein, S1
Aguilera, S; Benhmida, M; Deray, G; Desjobert, H; Jacobs, C; Le Hoang, P1
Farinelli, R; Fiocchi, O; Malacarne, F; Nunzi, L; Scaramuzzo, P; Scorrano, R; Tataranni, G; Zavagli, G1
Nussenblatt, R1
Aupetit, B; Baumelou, A; Benhmida, M; Deray, G; Jacobs, C; Le Hoang, P; Maksud, P1
Feutren, G; Mihatsch, MJ1
Austin, HA; de Smet, MD; Lopez, JS; Nussenblatt, RB; Rubin, BI; Whitcup, SM1
Kawashima, H; Mochizuki, M1
Chan, CC; Mochizuki, M; Ni, M; Nussenblatt, RB1
Hirose, S; Matsuda, H; Ohno, S; Onoé, K; Sasamoto, Y1
McCluskey, P; Wakefield, D1
Buskila, D; Shoenfeld, Y; Sukenik, S1
Bragliani, G; Catarinelli, G; De Molfetta, V; De Rosa, C; Latanza, L; Pivetti-Pezzi, P; Rossi, A; Scorrano, R; Secchi, AG; Tognon, S1
Fujino, Y; Higashihara, E; Horiuchi, D; Inaba, G; Kaku, H; Kawashima, H; Mochizuki, M; Okumura, A; Tange, T1
Caspi, RR; Gery, I; McAllister, CG; Nussenblatt, RB1
Fujino, Y; Higashihara, E; Horiuchi, D; Kawashima, H; Mochizuki, M; Okumura, A; Tange, T1
Dinning, WJ; Kuwabara, T; Leake, W; Nussenblatt, RB1

Reviews

16 review(s) available for cyclosporine and Uveitis

ArticleYear
Cyclosporine A Delivery Platform for Veterinary Ophthalmology-A New Concept for Advanced Ophthalmology.
    Biomolecules, 2022, 10-20, Volume: 12, Issue:10

    Topics: Animals; Cyclosporine; Cytokines; Horses; Humans; Immunosuppressive Agents; Keratitis; Ophthalmology; Uveitis; Water

2022
Current standardized therapeutic approach for uveitis in Japan.
    Immunological medicine, 2019, Volume: 42, Issue:3

    Topics: Adalimumab; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Japan; Uveitis

2019
Treatment of chronic non-infectious uveitis and scleritis.
    Swiss medical weekly, 2019, 02-25, Volume: 149

    Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Enzyme Inhibitors; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Scleritis; Uveitis

2019
Ocular Inflammation: Can It Be a Sign of Activity of Weber-Christian Disease? A Case Report and Review of Literature.
    Ocular immunology and inflammation, 2016, Volume: 24, Issue:2

    Topics: Cataract Extraction; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Panniculitis, Nodular Nonsuppurative; Retinal Vasculitis; Uveitis; Visual Acuity; Young Adult

2016
Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:12

    Topics: Adrenal Cortex Hormones; Adult; Behcet Syndrome; Cyclosporine; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Infliximab; Male; Renal Dialysis; Treatment Outcome; Uveitis; Visual Acuity

2015
Cyclosporine: A Historical Perspective on Its Role in the Treatment of Noninfectious Uveitis.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2017, Volume: 33, Issue:4

    Topics: Cyclosporine; Humans; Immunosuppressive Agents; Uveitis

2017
Review: implants.
    Journal of ocular pharmacology, 1994,Winter, Volume: 10, Issue:4

    Topics: Animals; Cyclosporine; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Implants; Filtering Surgery; Fluorouracil; Ganciclovir; Glaucoma; Humans; Uveitis

1994
Clinical use of cyclosporine in ocular disease.
    International ophthalmology clinics, 1993,Fall, Volume: 33, Issue:4

    Topics: Autoimmune Diseases; Cyclosporine; Eye Diseases; Humans; Ophthalmic Solutions; Uveitis

1993
Immunologic mechanisms of uveitis. New targets for immunomodulation.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1997, Volume: 115, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antibodies, Monoclonal; Cell Adhesion Molecules; Cyclosporine; Humans; Immune Tolerance; Immunosuppressive Agents; Uveitis

1997
Immunotherapy for Behçet's disease.
    International reviews of immunology, 1997, Volume: 14, Issue:1

    Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Agents; Behcet Syndrome; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Immunotherapy; Ligands; Tacrolimus; Uveitis

1997
Uveitis in Behçet's disease.
    International reviews of immunology, 1997, Volume: 14, Issue:1

    Topics: Adrenal Cortex Hormones; Anterior Eye Segment; Behcet Syndrome; Cataract; Colchicine; Cyclosporine; Humans; Tacrolimus; Uveitis; Vitreous Body

1997
Immunosuppression in uveitis therapy.
    Springer seminars in immunopathology, 1999, Volume: 21, Issue:2

    Topics: Administration, Oral; Administration, Topical; Animals; Arrestin; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy; Methotrexate; Rats; Steroids; Tacrolimus; Uveitis

1999
Prediction of treatment outcome in uveitis.
    Developments in ophthalmology, 1999, Volume: 31

    Topics: Cells, Cultured; Cyclosporine; Humans; Immunosuppressive Agents; Lymphocytes; Prognosis; Treatment Outcome; Uveitis

1999
Review: uveitis and immunosuppressive drugs.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2001, Volume: 17, Issue:2

    Topics: Animals; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Sirolimus; Tacrolimus; Uveitis

2001
The expanding use of immunosuppression in the treatment of non-infectious ocular disease.
    Journal of autoimmunity, 1992, Volume: 5 Suppl A

    Topics: Bromocriptine; Corneal Transplantation; Cyclosporine; Drug Therapy, Combination; Endophthalmitis; Eye Diseases; Humans; Immunosuppression Therapy; Keratoconjunctivitis; Prednisone; Uveitis

1992
The possible role of prolactin in autoimmunity.
    American journal of reproductive immunology (New York, N.Y. : 1989), 1991, Volume: 26, Issue:3

    Topics: Animals; Antibody Formation; Arthritis, Experimental; Arthritis, Psoriatic; Autoantibodies; Autoimmune Diseases; Autoimmunity; Bromocriptine; Cyclosporine; Drug Synergism; Female; Humans; Hyperprolactinemia; Immunity, Cellular; Immunocompetence; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Pregnancy; Pregnancy Complications; Prolactin; Rats; Rheumatic Diseases; Uveitis

1991

Trials

18 trial(s) available for cyclosporine and Uveitis

ArticleYear
An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Behçet's disease in long-term remission.
    Japanese journal of ophthalmology, 2021, Volume: 65, Issue:6

    Topics: Behcet Syndrome; Cyclosporine; Humans; Infliximab; Prospective Studies; Treatment Outcome; Uveitis

2021
Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation.
    Japanese journal of ophthalmology, 2017, Volume: 61, Issue:2

    Topics: Adult; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Remission Induction; Uveitis; Vasodilator Agents

2017
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:1

    Topics: Adult; Chronic Disease; Cyclosporine; Everolimus; Female; Flow Cytometry; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Photometry; Pilot Projects; Prospective Studies; Recurrence; Sirolimus; Treatment Outcome; Uveitis; Visual Acuity; Young Adult

2013
Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study.
    Journal of the American Society of Nephrology : JASN, 2002, Volume: 13, Issue:12

    Topics: Adult; Atrophy; Cohort Studies; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrosis; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney; Kidney Tubules; Male; Middle Aged; Prospective Studies; Uveitis

2002
[Cyclosporine monitoring in patients with chronic uveitis].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2005, Volume: 102, Issue:4

    Topics: Adolescent; Adult; Biological Availability; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Uveitis

2005
[Intraocular inflammations. A diagnostic and therapeutic challenge].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2005, Volume: 102, Issue:4

    Topics: Antiviral Agents; Behcet Syndrome; Chronic Disease; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Prognosis; Recombinant Proteins; Uveitis; Vision, Low

2005
Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Arthritis and rheumatism, 2005, Volume: 52, Issue:8

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Resistance, Multiple; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retreatment; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis

2005
Renal outcome after ciclosporin-induced nephrotoxicity.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:3

    Topics: Adult; Aged; Blood Glucose; Colorimetry; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Prognosis; Prospective Studies; Uric Acid; Uveitis

2007
[Initial experience with therapy of endogenous uveitis with Consupren--the Czech cyclosporin A].
    Ceskoslovenska oftalmologie, 1994, Volume: 50, Issue:5

    Topics: Adult; Cyclosporine; Female; Humans; Male; Uveitis

1994
Renal hemodynamic effects of cyclosporine treatment in patients with chronic uveitis and normal native kidneys.
    Transplantation, 1994, Oct-27, Volume: 58, Issue:8

    Topics: Adult; Amino Acids; Blood Pressure; Cyclosporine; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Glucagon; Hemodynamics; Humans; Insulin; Kidney; Male; Middle Aged; Uveitis; Vascular Resistance

1994
Low-dose cyclosporine A nephrotoxicity in non-renal patients.
    Transplantation proceedings, 1994, Volume: 26, Issue:5

    Topics: Administration, Oral; Adult; Analysis of Variance; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Kidney; Male; Middle Aged; Prospective Studies; Psoriasis; Uveitis

1994
Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy.
    Clinical rheumatology, 1994, Volume: 13, Issue:2

    Topics: Adult; Behcet Syndrome; Cyclosporine; Female; Humans; Male; Time Factors; Treatment Outcome; Uveitis; Visual Acuity

1994
Combined cyclosporin A-steroid-MTX treatment in endogenous non-infectious uveitis.
    Journal of autoimmunity, 1993, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Autoimmune Diseases; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Fluocortolone; Humans; Male; Methotrexate; Middle Aged; Uveitis; Visual Acuity

1993
A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin.
    American journal of ophthalmology, 1993, May-15, Volume: 115, Issue:5

    Topics: Adult; Cyclosporine; Cyclosporins; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Prednisone; Uveitis; Vision Disorders; Visual Acuity

1993
Long-term follow-up of patients with chronic uveitis affecting the posterior pole treated with combination cyclosporine and ketoconazole.
    Ophthalmology, 1997, Volume: 104, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Ketoconazole; Longitudinal Studies; Middle Aged; Pilot Projects; Prednisone; Prospective Studies; Uveitis

1997
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, Jun-22, Volume: 96, Issue:13

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Daclizumab; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Immunotherapy; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Prednisone; Th1 Cells; Treatment Outcome; Uveitis

1999
Combined use of cyclosporine and ketoconazole in the treatment of endogenous uveitis.
    American journal of ophthalmology, 1992, Jun-15, Volume: 113, Issue:6

    Topics: Autoimmune Diseases; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Glomerular Filtration Rate; Humans; Ketoconazole; Uveitis

1992
Open noncontrolled multicenter long-term trial with ciclosporin in endogenous non-infectious uveitis.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1991, Volume: 202, Issue:4

    Topics: Adult; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Uveitis; Visual Acuity

1991

Other Studies

86 other study(ies) available for cyclosporine and Uveitis

ArticleYear
Ciclosporin A in bilateral auto-immune chronic posterior uveitis associated with macular oedema: a Long-term Observational Safety and Efficacy Study.
    Eye (London, England), 2022, Volume: 36, Issue:11

    Topics: Creatinine; Cyclosporine; Follow-Up Studies; Humans; Macular Edema; Retrospective Studies; Uveitis; Uveitis, Posterior

2022
Insights gained from Single-Cell analysis of immune cells on Cyclosporine A treatment in autoimmune uveitis.
    Biochemical pharmacology, 2022, Volume: 202

    Topics: Animals; Autoimmune Diseases; Cyclosporine; Disease Models, Animal; Mice; Single-Cell Analysis; Th17 Cells; Uveitis

2022
Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
    International ophthalmology, 2023, Volume: 43, Issue:1

    Topics: Acute Disease; Adrenal Cortex Hormones; Cyclosporine; Female; Humans; Inflammation; Male; Pregnancy; Retrospective Studies; Uveitis; Uveomeningoencephalitic Syndrome

2023
Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis following Cyclosporine for Uveitis.
    Ocular immunology and inflammation, 2020, 05-18, Volume: 28, Issue:4

    Topics: Cyclosporine; Epstein-Barr Virus Infections; Eye Infections, Viral; Fluorescein Angiography; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Male; Microscopy, Acoustic; Middle Aged; Uveitis

2020
Role of Multidrug Resistance Proteins in Nonresponders to Immunomodulatory Therapy for Noninfectious Uveitis.
    Translational vision science & technology, 2020, Volume: 9, Issue:5

    Topics: ATP Binding Cassette Transporter, Subfamily B; Cyclosporine; Humans; Immunomodulation; Uveitis; Uveomeningoencephalitic Syndrome

2020
Behavioral Conditioning of Immune Responses with Cyclosporine A in a Murine Model of Experimental Autoimmune Uveitis.
    Neuroimmunomodulation, 2017, Volume: 24, Issue:2

    Topics: Animals; Autoimmune Diseases; Conditioning, Classical; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Male; Mice; Neuroimmunomodulation; Th17 Cells; Uveitis

2017
Cyclosporine A-Loaded Nanocarriers for Topical Treatment of Murine Experimental Autoimmune Uveoretinitis.
    Molecular pharmaceutics, 2018, 07-02, Volume: 15, Issue:7

    Topics: Administration, Ophthalmic; Animals; Autoimmune Diseases; Cyclosporine; Disease Models, Animal; Drug Carriers; Eye Proteins; Female; Humans; Immunosuppressive Agents; Mice; Nanoparticles; Polyesters; Polyethylene Glycols; Retinol-Binding Proteins; Treatment Outcome; Uveitis

2018
Treatment of endotoxin-induced uveitis by topical application of cyclosporine a-loaded PolyGel™ in rabbit eyes.
    International journal of pharmaceutics, 2019, Oct-05, Volume: 569

    Topics: Administration, Topical; Animals; Aqueous Humor; Cyclosporine; Drug Carriers; Eye; Immunosuppressive Agents; Lipopolysaccharides; Male; Polyesters; Rabbits; Uveitis

2019
Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitis.
    Ophthalmology, 2014, Volume: 121, Issue:5

    Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclosporine; Drug Substitution; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisolone; Retrospective Studies; Treatment Failure; Treatment Outcome; Uveitis; Visual Acuity; Young Adult

2014
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience.
    Clinical rheumatology, 2015, Volume: 34, Issue:4

    Topics: Adult; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; HLA-B51 Antigen; Humans; Immunosuppressive Agents; Infliximab; Interferon-alpha; Macular Edema; Male; Middle Aged; Mycophenolic Acid; Prevalence; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Uveitis; Visual Acuity

2015
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
    Clinical rheumatology, 2015, Volume: 34, Issue:10

    Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD20; Audiometry; Cyclosporine; Dexamethasone; Female; Hearing Loss; Hearing Loss, Sensorineural; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Panuveitis; Prednisolone; Prednisone; Prognosis; Recurrence; Remission Induction; Rituximab; Uveitis; Uveomeningoencephalitic Syndrome

2015
Regulatory T cell levels and cytokine production in active non-infectious uveitis: in-vitro effects of pharmacological treatment.
    Clinical and experimental immunology, 2015, Volume: 179, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Cells, Cultured; Cyclosporine; Cytokines; Dexamethasone; Disease Progression; Female; Forkhead Transcription Factors; Humans; Infliximab; Lymphocyte Count; Male; Middle Aged; T-Lymphocytes, Regulatory; Uveitis; Young Adult

2015
[Therapy of intermediate uveitis].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2014, Volume: 111, Issue:12

    Topics: Adrenal Cortex Hormones; Combined Modality Therapy; Cyclosporine; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Intravitreal Injections; Treatment Outcome; Uveitis

2014
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
    Seminars in arthritis and rheumatism, 2015, Volume: 44, Issue:6

    Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis

2015
[Uveitic macular edema and the pharmacotherapy].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2015, Volume: 51, Issue:2

    Topics: Acetazolamide; Adrenal Cortex Hormones; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Azathioprine; Bevacizumab; Cyclosporine; Humans; Immunosuppressive Agents; Macular Edema; Methotrexate; Mycophenolic Acid; Tumor Necrosis Factor-alpha; Uveitis; Vision Disorders

2015
Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
    Yonsei medical journal, 2015, Volume: 56, Issue:4

    Topics: Adult; Behcet Syndrome; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Recurrence; Remission Induction; Treatment Outcome; Turkey; Uveitis; Visual Acuity

2015
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
    Seminars in arthritis and rheumatism, 2015, Volume: 45, Issue:3

    Topics: Adalimumab; Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Prednisone; Retreatment; Retrospective Studies; Sarcoidosis; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Young Adult

2015
BIRC4 Mutation: An Important Rare Cause of Uveitis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2015, Volume: 21, Issue:8

    Topics: Adalimumab; Antirheumatic Agents; Child; Cyclosporine; Epstein-Barr Virus Infections; Genetic Diseases, X-Linked; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Mutation; Treatment Outcome; Uveitis; X-Linked Inhibitor of Apoptosis Protein

2015
[Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2015, Volume: 51, Issue:10

    Topics: Animals; Autoimmune Diseases; Cyclosporine; Down-Regulation; Eye Proteins; Immunosuppressive Agents; Interferon-gamma; Interleukin-17; Isoxazoles; Leflunomide; Random Allocation; Rats; Rats, Inbred Lew; Retinitis; Retinol-Binding Proteins; RNA, Messenger; Th17 Cells; Uveitis

2015
Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis.
    Ocular immunology and inflammation, 2017, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Azathioprine; Behcet Syndrome; Child; Cyclosporine; Drug Combinations; Drug Resistance; Female; Fluorescein Angiography; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Tomography, Optical Coherence; Uveitis; Visual Acuity

2017
Sepsis During Immunosuppression for Sight-threatening Uveitis: The Flip side.
    Ocular immunology and inflammation, 2018, Volume: 26, Issue:2

    Topics: Adult; Aged; Azathioprine; Bacteremia; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Klebsiella Infections; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pneumocystis Infections; Prednisolone; Retrospective Studies; Uveitis

2018
Robert Burton Nussenblatt, MD, MPH (1948-2016), Physician-Scientist, Leading Ophthalmologist and Exemplary Teacher.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2017, Volume: 33, Issue:4

    Topics: Antibodies, Monoclonal, Humanized; Cyclosporine; Daclizumab; Eye Diseases; History, 20th Century; History, 21st Century; Humans; Immunoglobulin G; Immunosuppressive Agents; National Eye Institute (U.S.); Ophthalmologists; Physicians; United States; Uveitis

2017
Special Issue in Honor of Robert B. Nussenblatt, MD, MPH.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2017, Volume: 33, Issue:4

    Topics: Cyclosporine; Eye Diseases; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; National Eye Institute (U.S.); Ophthalmologists; Physicians; T-Lymphocytes; United States; Uveitis

2017
Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis.
    Eye (London, England), 2009, Volume: 23, Issue:5

    Topics: Adolescent; Adrenal Cortex Hormones; Arthritis, Juvenile; Child; Child, Preschool; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Retrospective Studies; Uveitis

2009
LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.
    Investigative ophthalmology & visual science, 2009, Volume: 50, Issue:1

    Topics: Animals; Autoimmune Diseases; Cyclosporine; Cytokines; Disease Models, Animal; Eye Proteins; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Lymphocyte Activation; Male; Rats; Rats, Inbred Lew; Retinitis; Retinol-Binding Proteins; T-Lymphocytes; Treatment Outcome; Uveitis

2009
Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case report.
    The Journal of rheumatology, 2008, Volume: 35, Issue:9

    Topics: Abatacept; Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoconjugates; Infusions, Intravenous; Prednisone; Treatment Outcome; Uveitis; Visual Acuity

2008
Gout attack with unusual ocular complications.
    Rheumatology international, 2009, Volume: 29, Issue:5

    Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Colchicine; Cyclosporine; Diuretics; Edema; Gout; Gout Suppressants; Humans; Intraocular Pressure; Male; Middle Aged; Optic Disk; Prednisolone; Trabeculectomy; Treatment Outcome; Uveitis

2009
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.
    The British journal of ophthalmology, 2010, Volume: 94, Issue:3

    Topics: Acute Disease; Adult; Antibodies, Monoclonal; Behcet Syndrome; Cyclosporine; Drug Evaluation; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Visual Acuity

2010
Cyclosporine for ocular inflammatory diseases.
    Ophthalmology, 2010, Volume: 117, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammation; Male; Middle Aged; Pemphigoid, Benign Mucous Membrane; Retrospective Studies; Scleritis; Treatment Outcome; Uveitis; Young Adult

2010
[Systemic voclosporin for uveitis treatment].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2010, Volume: 107, Issue:7

    Topics: Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intra-Arterial; Randomized Controlled Trials as Topic; Treatment Outcome; Uveitis

2010
Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis.
    Veterinary ophthalmology, 2010, Volume: 13, Issue:5

    Topics: Animals; Cyclosporine; Female; Horse Diseases; Horses; Immunosuppressive Agents; Infusion Pumps, Implantable; Male; Uveitis

2010
Induction of regulatory T cells by infliximab in Behcet's disease.
    Investigative ophthalmology & visual science, 2011, Jan-21, Volume: 52, Issue:1

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Behcet Syndrome; Colchicine; Cyclosporine; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Forkhead Transcription Factors; Humans; Infliximab; T-Lymphocytes, Regulatory; Toxoplasmosis, Ocular; Tumor Necrosis Factor-alpha; Uveitis; Uveomeningoencephalitic Syndrome

2011
Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
    Clinical immunology (Orlando, Fla.), 2011, Volume: 139, Issue:2

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aqueous Humor; Behcet Syndrome; Cyclosporine; Cytokines; Female; HLA-B27 Antigen; Humans; Interferon-gamma; Interleukin-10; Interleukin-15; Interleukin-17; Logistic Models; Male; Middle Aged; Th1 Cells; Th17 Cells; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Uveomeningoencephalitic Syndrome; Young Adult

2011
Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema.
    Ocular immunology and inflammation, 2011, Volume: 19, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Azathioprine; Cataract; Cataract Extraction; Cyclosporine; Expert Testimony; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Macular Edema; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Ophthalmologic Surgical Procedures; Surveys and Questionnaires; Uveitis; Young Adult

2011
Clinical outcomes of cyclosporine treatment for noninfectious uveitis.
    Korean journal of ophthalmology : KJO, 2012, Volume: 26, Issue:1

    Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Prednisolone; Republic of Korea; Retrospective Studies; Treatment Outcome; Uveitis; Visual Acuity

2012
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
    Ophthalmology, 2012, Volume: 119, Issue:8

    Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Glucocorticoids; Humans; Injections, Subcutaneous; Macula Lutea; Male; Methotrexate; Off-Label Use; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Visual Acuity

2012
Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy.
    Japanese journal of ophthalmology, 2012, Volume: 56, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Behcet Syndrome; Colchicine; Cyclosporine; Female; Glucocorticoids; Humans; Infliximab; Infusions, Intravenous; Male; Middle Aged; Retinitis; Retrospective Studies; Uveitis; Visual Acuity; Young Adult

2012
A new drug delivery system inhibits uveitis in an animal model after cataract surgery.
    International journal of pharmaceutics, 2013, Feb-25, Volume: 443, Issue:1-2

    Topics: Animals; Anti-Inflammatory Agents; Biocompatible Materials; Cataract Extraction; Cyclosporine; Disease Models, Animal; Drug Carriers; Drug Combinations; Drug Delivery Systems; Female; Lactic Acid; Lens Implantation, Intraocular; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Triamcinolone Acetonide; Uveitis

2013
[Tubulointerstitial nephritis and uveitis (TINU syndrome) - comorbidity and complications in four patients].
    Klinische Monatsblatter fur Augenheilkunde, 2002, Volume: 219, Issue:7

    Topics: Adolescent; Arthritis, Rheumatoid; Autoimmune Diseases; Child; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Methotrexate; Mycophenolic Acid; Nephritis, Interstitial; Patient Care Team; Syndrome; Thyroiditis, Autoimmune; Treatment Outcome; Uveitis

2002
Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells.
    Clinical and experimental immunology, 2003, Volume: 133, Issue:2

    Topics: Adult; Chronic Disease; Cyclosporine; Dendritic Cells; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunophenotyping; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-12; Lymphocyte Culture Test, Mixed; Male; Middle Aged; Prednisone; Th1 Cells; Uveitis

2003
Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2003, Volume: 241, Issue:12

    Topics: Adult; Azathioprine; Chronic Disease; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Retrospective Studies; Treatment Outcome; Uveitis

2003
Pseudotumor cerebri following cyclosporine A treatment in a boy with tubulointerstitial nephritis associated with uveitis.
    Pediatric nephrology (Berlin, Germany), 2004, Volume: 19, Issue:5

    Topics: Adrenal Cortex Hormones; Child; Cyclosporine; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mycophenolic Acid; Nephritis, Interstitial; Pseudotumor Cerebri; Tomography, X-Ray Computed; Uveitis

2004
[Intraocular implantation of cyclosporine A drug delivery system in the treatment of experimental uveitis].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2005, Volume: 41, Issue:7

    Topics: Animals; Cyclosporine; Drug Delivery Systems; Drug Implants; Female; Immunosuppressive Agents; Male; Rabbits; Random Allocation; Uveitis; Vitreous Body

2005
Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:4

    Topics: Absorbable Implants; Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Female; Immunosuppressive Agents; Male; Polyesters; Rabbits; Uveitis; Vitreous Body

2006
Use of systemic cyclosporin A in a case of severe Toxocara uveitis.
    The Journal of infection, 2006, Volume: 52, Issue:5

    Topics: Adult; Animals; Cyclosporine; Female; Humans; Immunosuppressive Agents; Toxocara canis; Toxocariasis; Uveitis

2006
Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:2

    Topics: Animals; Aqueous Humor; Biocompatible Materials; Cyclosporine; Disease Models, Animal; Drug Carriers; Electroretinography; Eye; Immunosuppressive Agents; Injections; Lactic Acid; Leukocyte Count; Leukocytes; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Solubility; Uveitis

2006
Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
    Investigative ophthalmology & visual science, 2006, Volume: 47, Issue:9

    Topics: Animals; Biocompatible Materials; Chromatography, High Pressure Liquid; Cyclosporine; Drug Carriers; Immunosuppressive Agents; Lactic Acid; Microscopy, Electron, Scanning; Microscopy, Phase-Contrast; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Surface Properties; Uveitis; Vitreous Body

2006
The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis.
    Indian journal of ophthalmology, 2006, Volume: 54, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arrestin; Autoimmune Diseases; Biomarkers; Cyclosporine; Cytokines; Disease Models, Animal; Follow-Up Studies; Immunosuppressive Agents; Infliximab; Injections, Intraperitoneal; Interleukin-10; Male; Rats; Rats, Inbred Lew; Recombinant Proteins; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Vitreous Body

2006
Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis.
    Ophthalmology, 2007, Volume: 114, Issue:5

    Topics: Adolescent; Adult; Azathioprine; Child; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Tacrolimus; Treatment Outcome; Uveitis

2007
EULAR recommendations for the management of Behçet disease.
    Annals of the rheumatic diseases, 2008, Volume: 67, Issue:12

    Topics: Anticoagulants; Arthritis; Behcet Syndrome; Cyclosporine; Evidence-Based Medicine; Gastrointestinal Diseases; Humans; International Cooperation; Nervous System Diseases; Skin Diseases; Uveitis; Vascular Diseases

2008
Cyclosporin A in the ocular fluids of uveitis patients following long-term systemic administration.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:7

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aqueous Humor; Autoimmune Diseases; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lens Capsule, Crystalline; Male; Middle Aged; Tandem Mass Spectrometry; Tears; Uveitis

2008
[Outcome of Behçet disease in ophthalmologic practice in Morocco].
    Journal francais d'ophtalmologie, 1995, Volume: 18, Issue:5

    Topics: Adult; Behcet Syndrome; Chlorambucil; Cyclosporine; Eye Diseases; Female; Humans; Male; Morocco; Prednisone; Prognosis; Retinal Diseases; Time Factors; Uveitis

1995
Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.
    Journal of immunology (Baltimore, Md. : 1950), 1995, Jan-15, Volume: 154, Issue:2

    Topics: Animals; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Drug Synergism; Eye Proteins; Immunosuppressive Agents; Lymph Nodes; Lymphocyte Activation; Male; Polyenes; Rats; Rats, Inbred Lew; Retinitis; Sirolimus; Uveitis

1995
Leflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis rats.
    Agents and actions, 1994, Volume: 42, Issue:3-4

    Topics: Administration, Oral; Administration, Topical; Animals; Antibodies; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Eye Proteins; Freund's Adjuvant; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Retina; Uveitis

1994
Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.
    American journal of ophthalmology, 1994, Jul-15, Volume: 118, Issue:1

    Topics: Adolescent; Adult; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Male; Middle Aged; Prednisone; Uveitis; Visual Acuity

1994
Cyclosporine A induced colitis and acquired selective IgA deficiency in a patient with juvenile chronic arthritis.
    The Journal of rheumatology, 1993, Volume: 20, Issue:8

    Topics: Arthritis, Juvenile; Child; Colitis; Cyclosporine; Female; Humans; IgA Deficiency; Naproxen; Uveitis

1993
[Comments on the contribution by S. Klein et al. Cyclosporin A in therapy of chronic uveitis].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1993, Volume: 90, Issue:3

    Topics: Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Humans; Metabolic Clearance Rate; Uveitis

1993
Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis.
    Ophthalmology, 1996, Volume: 103, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Ophthalmic Solutions; Prednisone; Retrospective Studies; Uveitis; Visual Acuity

1996
Effects of cyclosporin A on the induction of oral tolerance.
    Annals of the New York Academy of Sciences, 1996, Feb-13, Volume: 778

    Topics: Administration, Oral; Animals; Antigens; Arrestin; Autoantigens; Autoimmune Diseases; Clonal Anergy; Cyclosporine; Eye Proteins; Immune Tolerance; Immunity, Cellular; Immunosuppressive Agents; Lymphocyte Activation; Male; Rats; Rats, Inbred Lew; Uveitis

1996
Cyclosporine A and the equine cornea.
    Equine veterinary journal, 1995, Volume: 27, Issue:5

    Topics: Animals; Cornea; Corneal Diseases; Cyclosporine; Horse Diseases; Horses; Uveitis

1995
Ophthalmic cyclosporine in equine keratitis and keratouveitis: 11 cases.
    Equine veterinary journal, 1995, Volume: 27, Issue:5

    Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Cornea; Corneal Ulcer; Cyclosporine; Female; Glaucoma; Horse Diseases; Horses; Immunosuppressive Agents; Keratitis; Male; Retrospective Studies; Uveitis

1995
An intravitreal device providing sustained release of cyclosporine and dexamethasone.
    Current eye research, 1996, Volume: 15, Issue:5

    Topics: Animals; Cataract; Cyclosporine; Dexamethasone; Drug Implants; Female; Male; Rabbits; Time Factors; Uveitis; Vitreoretinopathy, Proliferative; Vitreous Body

1996
Synergism between long-acting bromocryptine microcapsules and cyclosporine A in the prevention of various autoimmune diseases in rats.
    Experientia, 1996, Sep-15, Volume: 52, Issue:9

    Topics: Animals; Arthritis, Experimental; Autoimmune Diseases; Bromocriptine; Cyclosporine; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Drug Synergism; Female; Male; Ornithine Decarboxylase; Polyarteritis Nodosa; Rats; Rats, Inbred BB; Rats, Inbred Lew; Rats, Sprague-Dawley; Thymus Gland; Uveitis

1996
Cyclosporine monitoring with levels 6 hours after the morning dose in patients with noninfectious uveitis.
    Ophthalmology, 1997, Volume: 104, Issue:2

    Topics: Adult; Aged; Creatine; Cyclosporine; Drug Monitoring; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Middle Aged; Prospective Studies; Recurrence; Technetium Tc 99m Pentetate; Uveitis

1997
Phenotypic analysis of retinal leukocyte infiltration during combined cyclosporin A and nasal antigen administration of retinal antigens: delay and inhibition of macrophage and granulocyte infiltration.
    Ocular immunology and inflammation, 1997, Volume: 5, Issue:2

    Topics: Administration, Intranasal; Animals; Antigens; Autoimmune Diseases; Cattle; Chemotaxis, Leukocyte; Choroid; Cyclosporine; Drug Therapy, Combination; Eye Proteins; Female; Flow Cytometry; Granulocytes; Immunophenotyping; Leukocyte Count; Macrophages; Rats; Rats, Inbred Lew; Retina; T-Lymphocytes; Uveitis

1997
The importance of plasma polymorphonuclear (PMN) elastase determination in patients with uveitis.
    Acta ophthalmologica Scandinavica, 1997, Volume: 75, Issue:3

    Topics: Adolescent; Adult; Biomarkers; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Leukocyte Count; Leukocyte Elastase; Male; Middle Aged; Treatment Outcome; Uveitis

1997
Cyclosporine and neovascularization.
    Ophthalmology, 1999, Volume: 106, Issue:1

    Topics: Animals; Corneal Neovascularization; Cyclosporine; Mice; T-Lymphocytes; Uveitis

1999
Cyclosporin A therapy in refractory non-infectious childhood uveitis.
    The British journal of ophthalmology, 1998, Volume: 82, Issue:7

    Topics: Adolescent; Arthritis, Juvenile; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Retrospective Studies; Treatment Outcome; Uveitis; Visual Acuity

1998
[Suppression of experimental autoimmune uveoretinitis with a combination of cyclosporin and allopurinol].
    Nippon Ganka Gakkai zasshi, 1999, Volume: 103, Issue:1

    Topics: Allopurinol; Animals; Autoimmune Diseases; Cyclosporine; Free Radical Scavengers; Immunosuppressive Agents; Male; Rats; Rats, Inbred Lew; Retinitis; Uveitis; Xanthine Oxidase

1999
[Behcet's disease].
    Nederlands tijdschrift voor geneeskunde, 1999, Jan-23, Volume: 143, Issue:4

    Topics: Adult; Behcet Syndrome; Colchicine; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Prednisone; Sexually Transmitted Diseases; Stomatitis, Aphthous; Treatment Outcome; Uveitis; Vulvar Diseases

1999
Effect of an intravitreal cyclosporine implant on experimental uveitis in horses.
    Veterinary immunology and immunopathology, 2000, Oct-31, Volume: 76, Issue:3-4

    Topics: Animals; Aqueous Humor; Cyclosporine; Drug Implants; Horse Diseases; Horses; Immunohistochemistry; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphocyte Count; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Uveitis

2000
Oral diagnosis of Behcet disease in an eleven-year old girl and the non-surgical treatment of her gingival overgrowth caused by Cyclosporine.
    The Journal of clinical pediatric dentistry, 2001,Fall, Volume: 26, Issue:1

    Topics: Behcet Syndrome; Child; Cyclosporine; Dental Plaque; Dental Prophylaxis; Diagnosis, Differential; Female; Follow-Up Studies; Gingival Hemorrhage; Gingival Overgrowth; Gingivitis; Humans; Immunosuppressive Agents; Oral Hygiene; Patient Care Planning; Treatment Outcome; Uveitis

2001
Use of an intravitreal sustained-release cyclosporine delivery device for treatment of equine recurrent uveitis.
    American journal of veterinary research, 2001, Volume: 62, Issue:12

    Topics: Animals; Cyclosporine; Delayed-Action Preparations; Electroretinography; Female; Horse Diseases; Horses; Immunosuppressive Agents; Male; Uveitis

2001
[Cyclosporin A in therapy of chronic uveitis].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1992, Volume: 89, Issue:5

    Topics: Administration, Oral; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Recurrence; Uveitis

1992
Effects of cyclosporine on tubular acidification function in patients with idiopathic uveitis.
    American journal of nephrology, 1992, Volume: 12, Issue:6

    Topics: Acidosis, Renal Tubular; Adult; Aged; Aldosterone; Bicarbonates; Carbon Dioxide; Cyclosporine; Electrolytes; Female; Humans; Hydrogen-Ion Concentration; Kidney Tubules; Male; Middle Aged; Osmolar Concentration; Potassium; Sodium; Sodium Bicarbonate; Urine; Uveitis

1992
Usefulness of the assessment of urinary enzymes and microproteins in monitoring ciclosporin nephrotoxicity.
    Nephron, 1992, Volume: 60, Issue:3

    Topics: Acetylglucosaminidase; Adolescent; Adult; beta 2-Microglobulin; Biomarkers; Cyclosporine; Female; gamma-Glutamyltransferase; Humans; Kidney; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Proteinuria; Reference Values; Uveitis

1992
Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis.
    Annals of internal medicine, 1992, Oct-01, Volume: 117, Issue:7

    Topics: Adult; Autoimmune Diseases; Cholesterol; Creatinine; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Potassium; Triglycerides; Uric Acid; Uveitis

1992
Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases.
    The New England journal of medicine, 1992, Jun-18, Volume: 326, Issue:25

    Topics: Adolescent; Adult; Age Factors; Autoimmune Diseases; Blood Pressure; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Psoriasis; Retrospective Studies; Risk Factors; Sjogren's Syndrome; Uveitis

1992
Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat.
    Autoimmunity, 1990, Volume: 8, Issue:1

    Topics: Animals; Antibodies; Antigens; Arrestin; Autoimmune Diseases; Body Weight; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Eye; Eye Proteins; Guanidines; Immunosuppressive Agents; Male; Rats; Rats, Inbred Lew; Tacrolimus; Uveitis

1990
FR900506 (FK506) and 15-deoxyspergualin (15-DSG) modulate the kinetics of infiltrating cells in eyes with experimental autoimmune uveoretinitis.
    Autoimmunity, 1990, Volume: 8, Issue:1

    Topics: Animals; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Eye Proteins; Guanidines; Immunoenzyme Techniques; Immunosuppressive Agents; Macrophages; Male; Rats; Rats, Inbred Lew; Retina; T-Lymphocyte Subsets; Tacrolimus; Uveitis

1990
Topical application of ciclosporin ophthalmic solution containing alpha-cyclodextrin in experimental uveitis.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1991, Volume: 203, Issue:3

    Topics: Administration, Topical; alpha-Cyclodextrins; Animals; Antigens; Arrestin; Cyclodextrins; Cyclosporine; Disease Models, Animal; Drug Carriers; Eye Proteins; Male; Ophthalmic Solutions; Phosphodiesterase Inhibitors; Rabbits; Rats; Rats, Inbred Lew; Retinol-Binding Proteins; Uveitis; Vitreous Body

1991
Cyclosporine: a therapy in inflammatory eye disease.
    Journal of ocular pharmacology, 1991,Fall, Volume: 7, Issue:3

    Topics: Adult; Aged; Arthritis, Reactive; Blood Pressure; Creatinine; Cyclosporine; Eye Diseases; Female; Follow-Up Studies; Hirsutism; Humans; Male; Middle Aged; Recurrence; Sarcoidosis; Treatment Outcome; Tremor; Uveitis; Uveomeningoencephalitic Syndrome; Visual Acuity

1991
Cyclosporine G and D in experimental autoimmune uveoretinitis in the rat.
    Japanese journal of ophthalmology, 1989, Volume: 33, Issue:4

    Topics: Animals; Antibody Formation; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Cyclosporins; Eye Proteins; Immunity, Cellular; Kidney; Kidney Function Tests; Male; Rats; Rats, Inbred Lew; Retinitis; Skin Tests; Uveitis

1989
Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis.
    Cellular immunology, 1988, Volume: 113, Issue:2

    Topics: Animals; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Cyclosporins; Eye Proteins; Immunosuppression Therapy; Interleukin-1; Interleukin-2; Lymphocyte Activation; Lymphocyte Cooperation; Pineal Gland; Rats; Rats, Inbred Lew; Receptors, Immunologic; Receptors, Interleukin-2; Recombinant Proteins; Retinitis; T-Lymphocytes, Helper-Inducer; Uveitis

1988
[The effects of cyclosporine G and D treatment on experimental autoimmune uveoretinitis and kidney in rats].
    Nippon Ganka Gakkai zasshi, 1987, Volume: 91, Issue:10

    Topics: Animals; Autoimmune Diseases; Cyclosporine; Cyclosporins; Kidney; Rats; Rats, Inbred Lew; Retinitis; Uveitis

1987
The induction of tolerance by cyclosporine-G in experimental autoimmune uveitis in the Lewis rat.
    Journal of ocular pharmacology, 1987,Summer, Volume: 3, Issue:2

    Topics: Animals; Antigens; Arrestin; Autoimmune Diseases; Cell Division; Cyclosporine; Cyclosporins; Eye Proteins; Female; Immune System; Immune Tolerance; Lymph Nodes; Rats; Rats, Inbred Lew; Uveitis

1987